Paul J Dunford is a notable inventor based in Solana Beach, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the histamine H4 receptor. With a total of 2 patents, his work has the potential to impact the treatment of various medical conditions.

Latest Patents

Dunford's latest patents include innovative compounds such as diamino-pyridine, pyrimidine, and pyridazine, which may be utilized as H-receptor modulators. These compounds are designed for use in pharmaceutical compositions and methods aimed at treating disease states, disorders, and conditions mediated by H-receptor activity. This includes conditions such as allergy, asthma, autoimmune diseases, and pruritis. Another significant patent focuses on diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor, further emphasizing his commitment to advancing therapeutic options in this area.

Career Highlights

Dunford is currently associated with Janssen Pharmaceutica NV, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a strong focus on addressing unmet medical needs through the creation of effective compounds.

Collaborations

Some of his notable coworkers include Hui Cai and Frank Chavez, who contribute to the collaborative environment that fosters innovation at Janssen Pharmaceutica NV.

Conclusion

Paul J Dunford's contributions to pharmaceutical science through his patents and collaborative efforts highlight his role as a key innovator in the field. His work promises to enhance treatment options for various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.